Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Evanthia Galanis

1-50 of 124 results

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

scientific article published on March 15, 2010

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study

scientific article published on 5 July 2005

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial

scientific article published on July 2016

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

scientific article published on February 2007

Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme

scientific article published on April 2005

Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study

scientific article

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

scientific article published on 28 July 2009

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

scientific article

Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel

scientific article published in March 2007

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

scientific article

Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model

scientific article

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

scientific article published on November 16, 2011

Intraperitoneal therapy of ovarian cancer using an engineered measles virus.

scientific article published in August 2002

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

scientific article (publication date: September 2015)

Vorinostat in solid and hematologic malignancies

scientific article

Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma

scientific article

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

scientific article

Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods

scientific article published on 2 March 2006

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

scientific article published on April 15, 2003

Clinical trial end points for high-grade glioma: the evolving landscape.

scientific article published on 09 February 2011

Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity

scientific article published on December 2006

Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial

scientific article published on 05 July 2013

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

scientific article published on 7 September 2017

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

scientific article published on 27 April 2006

Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer

scientific article published on 24 January 2013

Engineered measles virus as a novel oncolytic therapy against prostate cancer

scientific article published on January 2009

Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas

scientific article published on 13 February 2007

Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview

scientific article published on February 2009

Toxicology study of repeat intracerebral administration of a measles virus derivative producing carcinoembryonic antigen in rhesus macaques in support of a phase I/II clinical trial for patients with recurrent gliomas

scientific article

Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity

scientific article published on 29 July 2008

Oncolytic measles virus strains in the treatment of gliomas

scientific article published on 01 February 2008

Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter

scientific article

PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel

scientific article published on June 2008

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

scientific article published on September 23, 2010

Phase II trial of gemcitabine in advanced sarcomas

scientific article

Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme

scientific article published on December 2007

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

scientific article published on December 18, 2014

Treatment of medulloblastoma with a modified measles virus

scientific article

Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model

scientific article

Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

scientific article published on February 14, 2013

Oncolytic measles virus strains as novel anticancer agents

scientific article published on 06 January 2013

Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm

scientific article

Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment

scientific article published on 23 September 2016

Biodistribution of Oncolytic Measles Virus After Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice

scientific article published on November 1, 2003

The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab

scientific article published on 21 October 2015

Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute

scientific article published on 25 February 2012

Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples

scientific article

Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus

scientific article

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

scientific article published in May 2017

Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein

scientific article published on December 21, 2010